Ascendis Health Limited (JSE: ASC)
South Africa
· Delayed Price · Currency is ZAR 72.00
0.00 (0.00%)
Sep 12, 2024, 1:56 PM SAST
Ascendis Health Revenue
In the fiscal year ending June 30, 2024, Ascendis Health had annual revenue of 1.47B ZAR, down -4.13%. Ascendis Health had revenue of 734.49M in the half year ending June 30, 2024, a decrease of -6.05%.
Revenue
1.47B
Revenue Growth
-4.13%
P/S Ratio
0.31
Revenue / Employee
105.15M
Employees
14
Market Cap
450.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 1.47B | -63.39M | -4.13% |
| Jun 30, 2023 | 1.54B | -24.02M | -1.54% |
| Jun 30, 2022 | 1.56B | -266.01M | -14.57% |
| Jun 30, 2021 | 1.83B | -377.56M | -17.14% |
| Jun 30, 2020 | 2.20B | -3.67B | -62.48% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAscendis Health News
- 1 day ago - Ascendis gets FDA orphan drug status for Yorvipath for hypothyroidism - Seeking Alpha
- 7 days ago - Ascendis raised to outperform by Oppenheimer ahead of drug launch - Seeking Alpha
- 9 days ago - Ascendis stock falls 12% amid lowered outlook, royalty deal - Seeking Alpha
- 9 days ago - Ascendis and Royalty Pharma enter into $150M royalty funding agreement - Seeking Alpha